Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: A critical review

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 1, 2009, Pages 38-46

  Dukic Ott A ^a   Thommes, M ^b   Remon, J P ^a   Kleinebudde, P ^b   Vervaet, C ^a  

^a GHENT UNIVERSITY   (Belgium)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Biopolymers; Extrusion; Microcrystalline cellulose; Pellets; Spheronisation

Indexed keywords

ALGINIC ACID; BARIUM SULFATE; BETA CYCLODEXTRIN; CALCIUM PHOSPHATE DIBASIC; CARRAGEENAN; CELLULOSE; CHITOSAN; CROSCARMELLOSE SODIUM; DICLOFENAC; DODECYL SULFATE SODIUM; EXCIPIENT; GLUCOSE; GLYCEROL STEARATE; HYDROCHLOROTHIAZIDE; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; MACROGOL; MANNITOL; MESALAZINE; MICROCRYSTALLINE CELLULOSE; PECTINIC ACID; PIROXICAM; POVIDONE; SORBITAN OLEATE; SORBITAN PALMITATE; SORBITOL; STARCH; STARCH GLYCOLATE SODIUM; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADSORPTION; CONTROLLED DRUG RELEASE; DRUG COATING; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INCOMPATIBILITY; DRUG SOLUBILITY; DRUG STABILITY; PARTICLE SIZE; PELLET EXTRUSION; QUALITY CONTROL; REVIEW; SPHERONIZATION;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 57349154376     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.08.005     Document Type: Review

References (104)

1. Ghebre-Sellassie I. Pellets: A general overview. In: Ghebre-Sellassie I. (Ed). Pharmaceutical Pelletization Technology (1989), Marcel Dekker Inc., New York and Basel 1-13
2. Bechgaard H., and Hagermann N.G. Controlled-release multi-units and single unit doses. A literature review. Drug. Dev. Ind. Pharm. 4 (1978) 53-67
3. Follonier N., and Doelker E. Biopharmaceutical comparison of an oral multiple-unit and single-unit sustained-release dosage forms. STP Pharm. Sci. 2 (1992) 141-158
4. Krämer J., and Blume H. Biopharmaceutical aspects of multiparticulates. In: Ghebre-Sellassie I. (Ed). Multiparticulate oral Drug Delivery (1994), Marcel Dekker Inc., New York, Basel and Hong Kong 307-332
5. Ghebre-Sellassie I., and Knoch A. Pelletization techniques. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology (2002), Marcel Dekker Inc., New York and Basel 2067-2080
6. Erkoboni K.A. Extrusion/spheronization. In: Ghebre-Sellassie I., and Martin C. (Eds). Pharmaceutical Extrusion Technology (2003), Marcel Dekker Inc., New York and Basel 277-322
7. Kleinebudde P., and Knop K. Direct pelletisation of pharmaceutical pellets in fluid-bed processes. In: Salman A.D., Hounslow M.J., and Seville J.P.K. (Eds). Handbook of Powder Technology: Granulation vol. II (2007), Elsevier, London 779-811
8. Trivedi N.R., Rajan M.G., Johnson J.R., and Shukla A.J. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronisation process. Critical Rev. Ther. Drug Carr. Syst. 24 (2007) 1-40
9. Newton J.M. Extrusion and extruders. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology (2002), Marcel Dekker Inc., New York and Basel 1220-1236
10. Reynolds A.D. A new technique for the production of spherical particles. Manuf. Chem. Aerosol News 41 (1970) 40-43
11. Conine J.W., and Hadley H.R. Preparation of small solid pharmaceutical spheres. Drug. Cosmet. Ind. 106 (1970) 38-41
12. Shah R.D., Kabadi M., Pope D.G., and Augsburger L.L. Physicomechanical characterization of the extrusion-spheronization process. 2. Rheological determinants for successful extrusion and spheronisation. Pharm. Res. 12 (1995) 496-507
13. Sonaglio D., Bataille B., Ortigosa C., and Jacob M. Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/spheronisation. Int. J. Pharm. 115 (1995) 53-60
14. Fielden K.E., Newton J.M., and Rowe R.C. The influence of lactose particle size on spheronization of extrudate processed by a ram extruder. Int. J. Pharm. 81 (1992) 205-224
15. Fielden K.E., Newton J.M., O'Brien P., and Rowe R.C. Thermal studies on the interaction of water and microcrystalline cellulose. J. Pharm. Pharmacol. 40 (1988) 674-678
16. Ek R., and Newton J.M. Microcrystalline cellulose as a sponge as an alternative concept to the crystallite-gel model for extrusion and spheronisation. Pharm. Res. 15 (1998) 509-511
17. Kleinebudde P. The crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronisation. Pharm. Res. 14 (1997) 804-809
18. Okada S., Nakahara H., and Isaka H. Adsorption of drugs on microcrystalline cellulose suspended in aqueous solutions. Chem. Pharm. Bull. 35 (1987) 761-768
19. Rivera S.L., and Ghodbane S. In vitro adsorption-desorption of famotidine on microcrystalline cellulose. Int. J. Pharm. 108 (1994) 31-38
20. Al-Nimry S.S., Assaf S.M., Jalal I.M., and Najib N.M. Adsorption of ketotifen onto some pharmaceutical excipients. Int. J. Pharm. 149 (1997) 115-121
21. Basit A.W., Newton J.M., and Lacey L.F. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm. Dev. Tech. 4 (1999) 499-505
22. Carstensen J.T., Osadca M., and Rubin S.H. Degradation mechanisms for water-soluble drugs in solid dosage forms. J. Pharm. Sci. 58 (1969) 549-553
23. Signoretti E.C., Dell'Utri A., DeSalvo A., and Donini L. Compatibility study between clenbuterol and tablet excipients using differential scanning calorimetry. Drug. Dev. Ind. Pharm. 12 (1986) 603-620
24. Patel N.K., Patel I.J., Cutie A.J., Wadke D.A., Monkhouse D.C., and Reier G.E. The effect of selected direct compression excipients on the stability of aspirin A as a model hydrolysable drug. Drug Dev. Ind. Pharm. 14 (1988) 77-98
25. George R.C., Barbuch R.J., Huber E.W., and Regg B.T. Investigation into the yellowing on aging Sabril tablet cores. Drug Dev. Ind. Pharm. 20 (1994) 3023-3032
26. Torres A.I., and Camacho M.A. Solid state interactions of two new antineoplastic drugs (mitonafide and amonafide) and common tablet excipients in preformulation studies. Eur. J. Pharm. Biopharm. 40 (1994) 41-43
27. Brandl M., Magill A., Rudraraju V., and Gordon M.S. Approaches for improving the stability of ketorolac in powder blends. J. Pharm. Sci. 84 (1995) 1151-1153
28. Newton J.M., Chow A.K., and Jeewa K.B. The effect of excipient source on spherical granules made by extrusion/spheronisation. Pharm. Technol. Int. 10 (1992) 52-58
29. O'Connor R.E., and Schwartz J.B. Spheronization II. Drug release from drug-diluent mixtures. Drug Dev. Ind. Pharm. 11 (1985) 1837-1857
30. Pinto J.F., Buckton G., and Newton J.M. The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronisation. Int. J. Pharm. 83 (1982) 187-196
31. Wan L.S.C., Heng P.W.S., and Liew C.V. Spheronization conditions on spheroid shape and size. Int. J. Pharm. 96 (1993) 59-65
32. Otsuka M., Gao J., and Matsuda Y. Effect of amount of added water during extrusion-spheronization process on pharmaceutical properties of granules. Drug Dev. Ind. Pharm. 20 (1994) 2977-2992
33. Umprayn K., Chitropas P., and Amarekajorn S. Influence of process variables on physical properties of the pellets using extruder and spheroniser. Drug Dev. Ind. Pharm. 25 (1999) 45-61
34. Blanqué D., Sternagel H., Podczeck F., and Newton J.M. Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronisation. Int. J. Pharm. 119 (1995) 203-211
35. Santos H., Veiga F., Pina M.E., Podczeck F., and Sousa J.J. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables. Int. J. Pharm. 246 (2002) 153-169
36. Sinha V.R., Agrawal M.K., and Kumria R. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronisation. Curr. Drug Deliv. 2 (2005) 1-8
37. Rodriguez E., Torrado J., Nikolakakis I., Torrado S., Lastres J., and Malamataris S. Micromeritic and packing properties of diclofenac pellets and effects of some formulation variables. Drug Dev. Ind. Pharm. 27 (2001) 847-855
38. Sousa J.J., Sousa A., Podczeck F., and Newton J.M. Influence of process conditions on drug release from pellets. Int. J. Pharm. 144 (1996) 159-169
39. Sousa J.J., Sousa A., Podczeck F., and Newton J.M. Factors influencing the physical characteristics of pellets obtained by extrusion-spheronization. Int. J. Pharm. 232 (2002) 91-106
40. Hellén L., Yliruusi J., and Kristoffersson E. Process variables of instant granulator and spheroniser: II. Size and size distributions of pellets. Int. J. Pharm. 96 (1993) 205-216
41. Hellén L., Yliruusi J., Merkku P., and Kristoffersson E. Process variables of instant granulator and spheroniser: I. Physical properties of granules, extrudate and pellets. Int. J. Pharm. 96 (1993) 197-204
42. Hellén L., and Yliruusi J. Process variables of instant granulator and spheroniser: III. Shape and shape distributions of pellets. Int. J. Pharm. 96 (1993) 217-223
43. Junnila R., Heinamaki J., and Yliruusi J. Effects of surface-active agent on the size, shape and hardness of microcrystalline cellulose/maize starch pellets prepared by an extrusion-spheronization technique. STP Pharm. Sci. 8 (1998) 221-226
44. Junnila R., Palviainen P., Heinämäki J., Myllärinen P., Forssell P., and Yliruusi J. Waxy corn starch: a potent cofiller in pellets produced by extrusion-spheronisation. Pharm. Dev. Tech. 5 (2000) 67-76
45. Gazzaniga A., Sangalli M.E., Bruni G., Zema L., Vecchio C., and Giordano F. The use of beta-cyclodextrin as a pelletization agent in the extrusion/spheronization process. Drug Dev. Ind. Pharm. 24 (1998) 869-873
46. Souto C., Rodriguez A., Parajes S., and Martinez-Pacheco R. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur. J. Pharm. Biopharm. 61 (2005) 94-99
47. Schröder M., and Kleinebudde P. Influence of formulation parameters on dissolution of propyphenasone pellets. Eur. J. Pharm. Biopharm. 41 (1995) 382-387
48. Mesiha M.S., and Vallés J. A screening study of lubricants in wet powder masses suitable for extrusion-spheronization. Drug Dev. Ind. Pharm. 19 (1993) 943-959
49. Edimo A., Leterme P., Denis J., Traisnel M., and Gayot A.T. Capacity of lipophilic auxiliary substances to give spheres by extrusion-spheronization. Drug Dev. Ind. Pharm. 19 (1993) 827-842
50. Law M.F.L., and Deasy P.B. Use of canonical and other analyses for the optimization of an extrusion-spheronization process for indomethacin. Int. J. Pharm. 146 (1997) 1-9
51. Law M.F.L., and Deasy P.B. Effect of common classes of excipients on extrusion-spheronization. J. Microencapsul. 14 (1997) 647-657
52. Deasy P.B., and Law M.F.L. Use of extrusion-spheronization to develop an improved oral dosage form of indomethacin. Int. J. Pharm. 148 (1997) 201-209
53. Vervaet C., Baert L., and Remon J.P. Enhancement of in-vitro drug-release by using polyethylene-glycol-400 and PEG-40 hydrogenated castor-oil in pellets made by extrusion/spheronisation. Int. J. Pharm. 108 (1994) 207-212
54. Newton M., Petersson J., Podczeck F., Clarke A., and Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J. Pharm. Sci. 90 (2001) 987-995
55. Newton J.M., Godinho A., Clarke A.P., and Booth S.W. Formulation variables on pellets containing self-emulsifying systems. Pharm. Technol. Eur. 17 (2005) 29-32
56. Tuleu C., Newton M., Rose J., Euler D., Saklatala R., Clarke A., and Booth S. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J. Pharm. Sci. 93 (2004) 1495-1502
57. Millili G.P., and Schwartz J.B. The strength of microcrystalline cellulose pellets - the effect of granulating with water ethanol mixtures. Drug Dev. Ind. Pharm. 16 (1990) 1411-1426
58. Schröder M., and Kleinebudde P. Structure of disintegrating pellets with regard to fractal geometry. Pharm. Res. 12 (1995) 1694-1700
59. Liew C.V., Gu L., Soh J.L.P., and Heng P.W.S. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose. Pharm. Res. 22 (2005) 1387-1398
60. th Edition).
61. Lindner H., and Kleinebudde P. Use of powdered cellulose for the production of pellets by extrusion/spheronisation. J. Pharm. Pharmacol. 46 (1994) 2-7
62. Fechner P.M., Wartewig S., Füting M., Heilmann A., Neubert R.H.H., and Kleinebudde P. Comparison of microcrystalline cellulose and powdered cellulose before and after extrusion/spheronization by FT-Raman spectroscopy and ESEM. AAPS Pharm. Sci. 5 (2003) 6. http://www.aapspharmsci.org/ article 32
63. El Saleh F., Jumaa M., Hassan I., and Kleinebudde P. Influence of cellulose type on the properties of extruded pellets. Part II: production and properties of pellets. STP Pharm. Sci. 10 (2000) 379-385
64. Alvarez L., Concheiro A., Gomez-Amoza J.L., Souto C., and Martinez-Pacheco R. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug. Eur. J. Pharm. Biopharm. 55 (2003) 291-295
65. O'Connor R.E., Holinej J., and Schwartz J.B. Spheronization I: processing and evaluation of spheres prepared of commercially available excipients. Am. J. Pharm. 156 (1984) 80-87
66. Funck J.A.B., Schwartz J.B., Reilly W.J., and Ghali E.S. Binder effectiveness for beads with high drug levels. Drug Dev. Ind. Pharm. 17 (1991) 1143-1156
67. Varshosaz J., Kennedy R.A., and Gipps E.M. Effect of binder level and granulating liquid on phenylbutazone pellets prepared by extrusion-spheronization. Drug Dev. Ind. Pharm. 23 (1997) 611-618
68. Kleinebudde P. Use of a power-consumption-controlled extruder in the development of pellet formulations. J. Pharm. Sci. 84 (1995) 1259-1264
69. Chopra R., Podczeck F., Newton J.M., and Aldeborn G. The influence of pellet shape and film coating on the filling of pellets into hard shell capsules. Eur. J. Pharm. Biopharm. 53 (2002) 327-333
70. Almeida Prieto S., Blanco Mendez J., and Otero Espinar F.J. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets. Eur. J. Pharm. Biopharm. 59 (2005) 511-521
71. Dukić A., Mens R., Adriaensens P., Foreman P., Gelan J., Remon J.P., and Vervaet C. Development of starch-based pellets via extrusion/spheronisation. Eur. J. Pharm. Biopharm. 66 (2007) 83-94
72. C.-W. Chiu, M. Henley, P. Altieri, Process for making amylase resistant starch from high amylose starch, US Patent 5,281,276 (1994).
73. D.T. Gordon, K. Topp, Y-C. Shi, J. Zallie, R. Jeffcoat, Resistant starch: physical and physiological properties, Frontiers Foods Food Ingred., 2 (New Technologies for Healthy Foods & Nutraceuticals) (1997) 157-178.
74. Dukić-Ott A., Remon J.P., Foreman P., and Vervaet C. Immediate release of poorly soluble drugs form starch-based pellets prepared by extrusion/spheronisation. Eur. J. Pharm. Biopharm. 67 (2007) 715-724
75. A. Dukić-Ott, T. De Beer, J.P. Remon, W. Baeyens, P. Foreman, C. Vervaet, In-vivo and in-vitro evaluation of enteric-coated starch-based pellet formulations, Eur. J. Pharm. Biopharm. (in press).
76. Goskonda S.R., and Upadrashta S.M. Avicel RC-591/chitosan beads by extrusion-spheronization technology. Drug Dev. Ind. Pharm. 19 (1993) 915-927
77. Tapia C., Buckton G., and Newton J.M. Factors influencing the mechanism of release from sustained-release matrix pellets, produced by extrusion spheronisation. Int. J. Pharm. 92 (1993) 211-218
78. Steckel H., and Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronisation. Eur. J. Pharm. Biopharm. 57 (2004) 107-114
79. Charoenthai N., Kleinebudde P., and Puttipipatkhachorn S. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose. AAPS PharmSciTech 8 (2007) Article 64
80. Agrawal A.M., Howard M.A., and Neau S.H. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables. Pharm. Dev. Tech. 9 (2004) 197-217
81. Jess K., and Steckel H. The extrusion and spheronisation of chitosan. Pharm. Technol. Eur. 7 (2007) 21-30
82. Charoenthai N., Kleinebudde P., and Puttipipatkhachorn S. Use of chitosan-alginate as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. J. Pharm. Sci. 96 (2007) 2469-2484
83. Agrawal A.M., Manek R.V., Kolling W.M., and Neau S.H. Water distribution studies within microcrystalline cellulose and chitosan using differential scanning calorimetry and dynamic water sorption analysis. J. Pharm. Sci. 93 (2004) 1766-1779
84. Garcia J., and Ghaly E.S. Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extrusion/marumerizer technique. Pharm. Dev. Technol. 6 (2001) 407-417
85. Bornhöft M., Thommes M., and Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. Eur. J. Pharm. Biopharm. 59 (2005) 127-131
86. Thommes M., and Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur. J. Pharm. Biopharm. 63 (2006) 59-67
87. Thommes M., and Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type. Eur. J. Pharm. Biopharm. 63 (2006) 68-75
88. Thommes M., Blaschek W., and Kleinebudde P. Effect of drying on extruded pellets based on kappa-Carrageenan. Eur. J. Pharm. Sci. 31 (2007) 112-118
89. NF 26/USP 31, United States Pharmacopoeia Convention, Rockville 2007.
90. Thommes M., and Kleinebudde P. The behavior of different Carrageenans in pelletisation by extrusion/spheronisation. Pharm. Dev. Technol. 13 1 (2008) 27-36
91. Thommes M., and Kleinebudde P. Properties of pellets manufactured by wet extrusion/spheronisation process using kappa-carrageenan: effect of process parameters. AAPS PharmSciTech 8 4 (2007) (article 95)
92. Tho I., Kleinebudde P., and Sande S. Extrusion/spheronization of pectin-based formulations. I. Screening of important factors. AAPS PharmSciTech 2 (2001) (article 26)
93. Tho I., Kleinebudde P., and Sande S. Extrusion/spheronization of pectin-based formulations. II. Effect of additive concentration in the granulation liquid. AAPS PharmSciTech 2 (2001) (article 27)
94. Tho I., Sande S.A., and Kleinebudde P. Pectinic acid, a novel excipient for production of pellets by extrusion/spheronisation: preliminary studies. Eur. J. Pharm. Biopharm. 54 (2002) 95-99
95. Tho I., Anderssen E., Dyrstad K., Kleinebudde P., and Sande S.A. Quantum chemical descriptors in the formulation of pectin pellets produced by extrusion/spheronisation. Eur. J. Pharm. Sci. 16 (2002) 143-149
96. Tho I., Sande S.A., and Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation. Eur. J. Pharm. Biopharm. 56 (2003) 371-380
97. Tho I., Sande S.A., and Kleinebudde P. Cross-linking of amidated low-methoxylated pectin with calcium during extrusion/spheronisation: effect of particle size and shape. Chem. Eng. Sci. 60 (2005) 3899-3907
98. Chatlapalli R., and Rohera B.D. Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. Int. J. Pharm. 161 (1998) 179-193
99. Chatlapalli R., and Rohera B.D. Rheological characterization of diltiazem HCl/cellulose wet masses using a mixer torque rheometer. Int. J. Pharm. 175 (1998) 47-59
100. Chatlapalli R., and Rohera B.D. Study of effect of excipient source variation on rheological behavior of diltiazem HC/HPMC wet masses using a mixer torque rheometer. Int. J. Pharm. 238 (2002) 139-151
101. Howard M.A., Neau S.H., and Sack J.S. PEO and MPEG in high drug load extruded and spheronised beads that are devoid of MCC. Int. J. Pharm. 307 (2006) 66-76
102. P. Verheyen, K.-J. Steffens, P. Kleinebudde, Use of crospovidone as pelletisation aid as alternative to microcrystalline cellulose: effects on pellet properties, 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Barcelona, 2008, pp. 1-2.
103. Newton J.M., Boutell S., Chatchawalsaisin J., and Podczeck F. The preparation of spherical granules by extrusion/spheronization without microcrystalline cellulose. Pharm. Technol. Eur. 10 (2004) 21-27
104. Chatchawalsaisin J., Podczeck F., and Newton J.M. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate. Eur. J. Pharm. Sci. 24 (2005) 35-48